By Dr. Ashley Morgan, assistant director of the AVMA GRD
Earlier this month, the Food and Drug Administration (FDA) held a two-day meeting to discuss antiparasitic drug use and resistance in ruminants and equines. The March 5 – 6th meeting focused on the current state of anthelmintic resistance around the world, tools for the evaluation of antiparasitic resistance, evaluation of drug effectiveness in resistant parasites, considerations for choosing and using anthelmintic combination products, and times for public comment and discussion. As academicians, researchers, veterinarians, and animal producers and owners all share a role in determining how anthelmintic drugs fit into specific parasite control programs, dialogue on scientific issues related to antiparasitic resistance is important.
If you would like to submit comments to the FDA regarding this issue, you may provide feedback online or in writing. The docket will remain open for comment until May 7, 2012. A transcript of the meeting will be prepared and posted on the Agency's website. For additional questions or concerns, please contact aleta [dot] sindelarfda [dot] hhs [dot] gov (Aleta Sindelar) or amorganavma [dot] org (Dr. Ashley Morgan).
For more information please contact amorganavma [dot] org (Dr. Ashley Morgan), assistant director, AVMA Governmental Relations Division.